Anaïs Schavgoulidze

10PUBLICATIONS
48CO-AUTHORS
Medical infection agents (incl. prions)Microelectromechanical systems (MEMS)Medical molecular engineering of nucleic acids and proteinsMedical mycologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 04, 2026
PKMYT1 is a Targetable Vulnerability in del(17p) High-Risk Multiple Myeloma.

|Oct 17, 2025
ID2 Suppresses Multiple Myeloma Cell Proliferation by Repressing the Activity of the Transcription Factor TCF3.

Mariateresa Fulciniti, Yao Yao, Tommaso Perini

|Sep 24, 2025
High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing.

Anaïs Schavgoulidze, Aurore Perrot, Xavier Leleu

|Nov 07, 2022
In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present From Diagnosis in Tiny, Undetectable Subclonal Populations.

Romain Lannes, Mehmet Samur, Aurore Perrot

|Feb 16, 2022
Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical features.

Titouan Cazaubiel, Xavier Leleu, Aurore Perrot

|Apr 03, 2021
Multiple Myeloma: Heterogeneous in Every Way.

Anaïs Schavgoulidze, Titouan Cazaubiel, Aurore Perrot

Pageof 2

Frequent Collaborators

7 joint publications

Aurore Perrot

7 joint publications

Jill Corre

4 joint publications

Xavier Leleu

3 joint publications

Mohamad Mohty